Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Akebia reports topline data from its PRO2TECT global phase III program of vadadustat

Sep. 4, 2020

Tohoku University divulges dioxolan derivatives for renal diseases

Sep. 2, 2020

Ardelyx divulges glycyrrhetinic derivatives for hyperkalemia

Sep. 1, 2020

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Aug. 31, 2020

Evotec and Novo Nordisk collaborate to develop novel therapies for CKD

Aug. 19, 2020

AstraZeneca is enrolling participants in phase I study of MEDI-8367

Aug. 7, 2020

Positive topline data presented from phase IIa ACTION study of DMX-200 in FSGS

July 30, 2020

Phase III DAPA-CKD trial of Farxiga meets all primary and secondary endpoints

July 28, 2020

Metabolic reprogramming promotes ADPKD cystogenesis

July 22, 2020

Goldfinch Bio begins phase IIa study of GFB-887 for renal diseases

July 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...